|
CENPJ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.510490E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.421400E-01 |
| Normal-vs-Stage2 |
2.417600E-01 |
| Normal-vs-Stage3 |
1.854620E-01 |
| Normal-vs-Stage4 |
4.521400E-01 |
| Stage1-vs-Stage2 |
3.956600E-01 |
| Stage1-vs-Stage3 |
3.583000E-01 |
| Stage1-vs-Stage4 |
6.019600E-01 |
| Stage2-vs-Stage3 |
7.489200E-01 |
| Stage2-vs-Stage4 |
7.862800E-01 |
| Stage3-vs-Stage4 |
9.485400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.203500E-02 |
| Normal-vs-AfricanAmerican |
1.167450E-01 |
| Normal-vs-Asian |
2.124800E-01 |
| Caucasian-vs-AfricanAmerican |
9.913800E-01 |
| Caucasian-vs-Asian |
9.460400E-01 |
| AfricanAmerican-vs-Asian |
9.563200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.216360E-01 |
| Normal-vs-Female |
1.200680E-03 |
| Male-vs-Female |
1.317630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.835000E-01 |
| Normal-vs-Extreme_Weight |
6.876400E-01 |
| Normal-vs-Obese |
4.317500E-02 |
| Normal-vs-Extreme_Obese |
1.600390E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.154000E-01 |
| Normal_Weight-vs-Obese |
4.465600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.404620E-01 |
| Extreme_Weight-vs-Obese |
8.291700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.108800E-01 |
| Obese-vs-Extreme_Obese |
7.668000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.113190E-01 |
| Normal-vs-Age(41-60Yrs) |
2.563400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.830750E-01 |
| Normal-vs-Age(81-100Yrs) |
3.445400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.876800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.576200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.585800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.731600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.859800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.049600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.339200E-03 |
| Normal-VS-Type2 PRCC |
2.036800E-01 |
| Normal-VS-KIRP CIMP |
1.554160E-01 |
| Normal-VS-Unclassified PRCC |
1.772220E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.71949999999899E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.165200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.630400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.094050E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.983100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.758200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.658800E-01 |
| Normal-vs-N1 |
4.215800E-03 |
| Normal-vs-N2 |
1.817770E-01 |
| N0-vs-N1 |
2.858900E-03 |
| N0-vs-N2 |
3.425000E-01 |
| N1-vs-N2 |
3.020200E-04 |
|
|
